Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,525.00
-5.00 (-0.20%)
Jan 6, 2026, 12:04 PM GMT
Genus Market Cap
Genus has a market cap or net worth of 1.69 billion as of January 6, 2026. Its market cap has increased by 65.51% in one year.
Market Cap
1.69B
Enterprise Value
1.91B
Revenue
672.80M
Ranking
n/a
PE Ratio
87.37
Stock Price
2,525.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.69B, an increase of 5,344.82%. That is a compound annual growth rate of 15.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 1.70B | -1.93% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 73.48B |
| Haleon | 32.96B |
| Smith & Nephew | 10.35B |
| Convatec Group | 4.67B |
| Hikma Pharmaceuticals | 3.37B |
| HUTCHMED (China) | 1.75B |
| Oxford Nanopore Technologies | 1.24B |